×

Once registered, you can:

  • - Read additional free articles each month
  • - Comment on articles and featured creative work
  • - Get our curated newsletters delivered to your inbox

By registering you agree to our privacy policy, terms & conditions and to receive occasional emails from Ad Age. You may unsubscribe at any time.

Are you a print subscriber? Activate your account.

PEPTO-BISMOL, METAMUCIL MOVE TO D'ARCY

Published on .

(July 26, 2001) -- Procter & Gamble Co. has moved its $30 million U.S. advertising accounts for Pepto-Bismol and Metamucil to Bcom3 Group's D'Arcy Masius Benton & Bowles, New York, from sibling shop Leo Burnett USA, Chicago.

The move consolidates the two gastrointestinal brands with D'Arcy, which already is agency of record for the hoped-for over-the-counter version of Prilosec.

P&G has OTC conversion rights for Prilosec, marketed by AstraZeneca as a prescription drug, and has told financial analysts it hopes to receive approval for the OTC conversion by next year.

Klemtner Advertising, New York, handles the prescription Prilosec account for AstraZeneca. -- Jack Neff

Copyright July 2001, Crain Communications Inc.

In this article:
Most Popular